EUDA Health Holdings Limited (EUDA)
NASDAQ: EUDA · Real-Time Price · USD
14.44
-0.46 (-3.09%)
At close: Oct 21, 2026, 4:00 PM EDT
14.22
-0.22 (-1.52%)
After-hours: Oct 21, 2026, 6:36 PM EDT
EUDA Health Holdings Revenue
EUDA Health Holdings had revenue of $3.47M in the half year ending June 30, 2026, with 81.75% growth. This brings the company's total for the last twelve months to $7.31M, up 41.57% year-over-year. In the year 2025, EUDA Health Holdings had annual revenue of $6.82M with 70.04% growth. That makes EUDA Health Holdings the 38,662nd largest company in the world by revenue and 5,092nd in the United States.
Revenue (ttm)
$7.31M
Revenue Growth
+41.57%
P/S Ratio
5.98
Revenue / Employee
$58,787
Employees
123
Market Cap
43.24M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full EUDA Health Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.82M | 2.81M | 70.04% |
| Dec 31, 2024 | 4.01M | 304.55K | 8.22% |
| Dec 31, 2023 | 3.71M | -57.84K | -1.54% |
| Dec 31, 2022 | 3.76M | - | - |
| Jul 31, 2022 | - | - | - |
| Dec 31, 2021 | 4.56M | -4.32M | -48.64% |
| Dec 31, 2020 | 8.88M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Douglas Elliman | 1.01B |
| Altisource Portfolio Solutions | 182.50M |
| Star Holdings | 98.27M |
| Fangdd Network Group | 39.33M |
| American Strategic Investment Co. | 33.41M |
| J.W. Mays | 21.43M |
| Linkhome Holdings | 20.80M |
| Seritage Growth Properties | 12.52M |
EUDA News
- 1 month ago - EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore - GlobeNewsWire
- 2 months ago - EUDA Health enters collaboration for integrated iPSC cell therapy program - TheFly
- 2 months ago - EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products - GlobeNewsWire
- 2 months ago - EUDA Health signs MoU with GO POSB Organoids, SIIT - TheFly
- 2 months ago - EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies - GlobeNewsWire
- 3 months ago - EUDA Health Holdings Ltd trading resumes - TheFly
- 3 months ago - EUDA Health Holdings Ltd trading halted, volatility trading pause - TheFly
- 4 months ago - EUDA Health regains Nasdaq compliance - TheFly